Alan White, business development director at The Translation People discusses how pharmaceutical businesses are operating in the post-Covid era.
Strategy
Never before has the pharmaceutical industry been under the spotlight in such a conjoined, simultaneous, global capacity.
Coronavirus has presented a whole new challenge; the industry is at a standing start in terms of a vaccine and needs to mobilise faster than ever, against unique restrictions and challenges. Almost as difficult as creating a vaccine itself is the industry’s ability to communicate the developments, issues and opportunities it presents in multiple languages.